Mounjaro (Tirzepatide) is a once-weekly injectable medication indicated for diabetes and has been proven effective for weight management.
It is a dual GLP-1 and GIP receptor agonist. Using Mounjaro leads to a reduced appetite, by slowing gastric emptying, leading to prolonged satiety after meals, and an improvement in the body’s ability to use and store energy. This dual effect enhances fat metabolism, leading to greater weight reduction compared to GLP-1 alone.
Availability of the medication is pharmacy dependent. Please confirm availability with your pharmacy before proceeding.
Do not continue with this questionnaire if you have any of the “⛔(do not proceed)” conditions below. Instead, please consult with our online doctors here for further assessment, medical workup or alternative weight management options.
If you are currently using Mounjaro please click here for the existing user form.
Mounjaro (Tirzepatide) is a once-weekly injectable medication indicated for diabetes and has been proven effective for weight management.
It is a dual GLP-1 and GIP receptor agonist. Using Mounjaro leads to a reduced appetite, by slowing gastric emptying, leading to prolonged satiety after meals, and an improvement in the body’s ability to use and store energy. This dual effect enhances fat metabolism, leading to greater weight reduction compared to GLP-1 alone.